Assetmark, Inc Natera, Inc. Transaction History

Assetmark, Inc

$32.1 Billion
Q2 2024

A detailed history of Assetmark, Inc transactions in Natera, Inc. stock. As of the latest transaction made, Assetmark, Inc holds 7,203 shares of NTRA stock, worth $905,561. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,203

Previous 4,158 73.23%

Holding current value

$905,561

Previous $380,000 105.26%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$85.28 - $112.6 $259,677 - $342,867	3,045 Added 73.23%	7,203 $780,000
Q1 2024 May 06, 2024	SELL	$59.21 - $92.9 $62,999 - $98,845	-1,064 Reduced 20.38%	4,158 $380,000
Q4 2023 Feb 09, 2024	BUY	$37.55 - $62.64 $49,678 - $82,872	1,323 Added 33.93%	5,222 $327,000
Q3 2023 Oct 27, 2023	BUY	$43.4 - $62.52 $23,956 - $34,511	552 Added 16.49%	3,899 $172,000
Q2 2023 Aug 11, 2023	SELL	$47.08 - $55.16 $3,766 - $4,412	-80 Reduced 2.33%	3,347 $162,000
Q1 2023 May 05, 2023	BUY	$36.57 - $58.29 $30,023 - $47,856	821 Added 31.5%	3,427 $190,000
Q4 2022 Feb 10, 2023	BUY	$34.17 - $47.91 $44,147 - $61,899	1,292 Added 98.33%	2,606 $104,000
Q3 2022 Nov 01, 2022	BUY	$36.93 - $56.68 $16,286 - $24,995	441 Added 50.52%	1,314 $58,000
Q2 2022 Aug 03, 2022	BUY	$28.13 - $44.54 $11,870 - $18,795	422 Added 93.57%	873 $31,000
Q1 2022 May 13, 2022	SELL	$30.32 - $91.33 $45,570 - $137,268	-1,503 Reduced 76.92%	451 $18,000
Q4 2021 Feb 14, 2022	BUY	$86.26 - $119.0 $152,507 - $210,392	1,768 Added 950.54%	1,954 $182,000
Q3 2021 Nov 12, 2021	BUY	$100.17 - $126.36 $18,631 - $23,502	186 New	186 $21,000
Q1 2020 May 12, 2020	SELL	$17.27 - $40.17 $535 - $1,245	-31 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$32.1 - $40.4 $32 - $40	1 Added 3.33%	31 $1,000
Q3 2019 Nov 13, 2019	BUY	$25.38 - $34.89 $761 - $1,046	30 New	30 $1,000

Others Institutions Holding NTRA

# of Institutions

504

Shares Held

120M

Call Options Held

412K

Put Options Held

270K

View Full List

About Natera, Inc.

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $12.2B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

More about NTRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.

Account